サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1794690

腎不全治療の世界市場

Renal Failure Treatment

出版日
ページ情報
英文 282 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.16円
腎不全治療の世界市場
出版日: 2025年08月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 282 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

腎不全治療の世界市場は2030年までに1,822億米ドルに到達

2024年に1,170億米ドルと推定される腎不全治療の世界市場は、2024～2030年の分析期間においてCAGR 7.7%で成長し、2030年には1,822億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである透析治療は、CAGR 9.1%を記録し、分析期間終了時には893億米ドルに達すると予想されます。腎移植治療セグメントの成長率は、分析期間でCAGR 5.4%と推定されます。

米国市場は319億米ドルと推定、中国はCAGR12.2％で成長予測

米国の腎不全治療市場は2024年に319億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに392億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは12.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.7%と7.4%と予測されています。欧州では、ドイツがCAGR 5.1%で成長すると予測されています。

世界の腎不全治療市場- 主要動向と促進要因まとめ

腎不全の情勢は統合医療と個別化医療へどのようにシフトしているか？

腎不全、特に末期腎不全（ESRD）は、慢性腎臓病（CKD）の最終段階であり、腎臓はもはや必要不可欠な濾過・調節機能を果たせなくなります。ESRD患者は、透析や腎移植を含む腎代替療法（RRT）を必要とします。糖尿病や高血圧などの慢性疾患に起因するESRDの世界の罹患率の増加は、急性期および長期的な管理戦略の最適化という大きなプレッシャーを医療システムに与えています。この変化は、早期診断、ケアコーディネーション、治療後のサポートを強化するための腎ケアの枠組みの再評価を促しています。

スクリーニング、薬理学的管理、食事カウンセリング、適時の透析導入などを統合した腎臓病ケアモデルが勢いを増しています。ナトリウム-グルコース共輸送体-2（SGLT2）阻害薬などの早期介入は、腎不全への進行を遅らせ、蛋白尿を減少させ、心血管リスクを低下させるのに効果的であることが証明されつつあります。これらの薬剤は現在、将来の透析依存を減らすために、CKD治療の早い段階で処方されています。さらに、モバイルヘルスプラットフォームと遠隔モニタリングツールは、特に在宅透析や移植前評価のための患者関与を促進し、転帰と費用効率を向上させています。

複雑な患者ニーズに対応するために進化している治療法は？

透析は依然として腎不全管理の要であり、血液透析（HD）と腹膜透析（PD）に分けられます。血液透析は、透析センターで行われ、最近では家庭でも行われるようになり、透析装置、ウェアラブル技術、高度なろ過膜の技術革新によって支えられています。対流的透析と拡散的透析を組み合わせたオンライン血液透析濾過（HDF）は、毒素除去を改善するために採用されつつあります。在宅血液透析システムは現在、コンパクトで持ち運びが可能で、接続が可能であるため、合併症が少なく、生活の質を向上させる個別化されたケアが可能になっています。

腹膜透析も、費用対効果と患者の自主性により、特にアジア太平洋とラテンアメリカで復活しつつあります。遠隔データ転送とスマートな輸液管理を備えた自動腹膜透析装置は、より安全で効率的なセルフケアを可能にしています。腎臓移植は依然として最も確実な治療法であるが、臓器不足、免疫抑制合併症、資格制限により、移植へのアクセスが制限されています。移植プールを拡大するために、ペア腎臓交換、脱感作プロトコル、ドナー臓器の正常温熱機械灌流などの取り組みが検討されています。免疫療法やバイオ人工腎臓のような再生アプローチは前臨床段階にあり、ESRD管理に長期的な可能性を提供しています。

市場の優先順位を変えつつある地域システムと患者集団は？

米国、日本、西欧のような高所得国は、成熟した透析・移植システムを有していますが、コスト抑制とESRD人口の高齢化という課題に直面しています。これらの地域では、透析の在宅化、遠隔医療の利用拡大、予防的腎臓内科サービスの導入に力を入れています。米国メディケアのESRDプログラムは、早期紹介と治療法の多様化に報いる一括支払いと質ベースの償還で進化を続けています。欧州では、ウェアラブル透析システムへの投資や、政策改革によるドナー臓器の利用拡大が進んでいます。

新興国は、CKD罹患率の上昇と腎臓内科インフラへの政府投資により、市場拡大の焦点となっています。中国の国家透析プログラム、インドのPradhan Mantri National Dialysis Program、ラテンアメリカのPPPモデルは、いずれも治療アクセスを拡大しています。しかし、経済的な余裕が依然として障壁となっており、低価格の透析装置、再利用可能な消耗品、ジェネリック免疫抑制剤に対する需要に拍車をかけています。若年層のESRD患者は、先天性または自己免疫疾患による影響を受けることが多く、生涯にわたる質の高い腎ケアを必要とする患者層です。こうした患者の存在は、コスト、技術革新、公平なアクセスのバランスを取るシステムに対する圧力を高めています。

腎不全治療市場の成長を促進する要因は？

腎不全治療市場の成長は、ESRDの有病率の上昇、透析インフラの拡大、移植率の増加、早期CKD治療法の革新によってもたらされます。CKDは多くの患者で診断されないまま進行し続けているため、医療システムは腎不全を遅らせたり管理したりするためのスクリーニングプログラムや慢性ケア経路に投資しています。在宅透析ソリューション、AIを活用した透析計画ツール、ウェアラブル透析機器は、治療をより身近で患者に優しいものにしつつあります。

移植は、臓器保存技術、生体ドナーの擁護、移植後のケアに対する政府の補助金によって後押しされています。腎保護剤、デジタルアドヒアランスプラットフォーム、ハイブリッド治療センターの開発により、CKD-ESRDの連続的な治療の質が向上しています。世界の資金調達イニシアティブ、PPPモデル、医療技術企業と製薬企業の戦略的提携は、十分なサービスを受けていない地域への市場参入を可能にしています。これらの力が相まって、腎不全治療市場は、精密性、アクセシビリティ、統合された慢性疾患管理によって定義される未来に向かって推進されています。

セグメント

治療（透析治療、腎移植治療、薬物療法治療、その他の治療）;エンドユーザー（病院エンドユーザー、専門クリニックエンドユーザー、その他のエンドユーザー）

調査対象企業の例

  • AbbVie Inc.
  • Akebia Therapeutics, Inc.
  • Amgen Inc.
  • Asahi Kasei Corporation
  • AstraZeneca PLC
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company（BD）
  • Calliditas Therapeutics AB
  • DaVita Inc.
  • Dialysis Clinic, Inc.（DCI）
  • Fresenius Medical Care AG & Co. KGaA
  • GSK plc
  • JMS Co., Ltd.
  • Medtronic plc
  • Nikkiso Co., Ltd.
  • NIPRO Corporation
  • Novartis AG
  • Otsuka Pharmaceutical Co., Ltd.
  • Toray Industries, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP37896

Global Renal Failure Treatment Market to Reach US$182.2 Billion by 2030

The global market for Renal Failure Treatment estimated at US$117.0 Billion in the year 2024, is expected to reach US$182.2 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. Dialysis Treatment, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$89.3 Billion by the end of the analysis period. Growth in the Kidney Transplantation Treatment segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$31.9 Billion While China is Forecast to Grow at 12.2% CAGR

The Renal Failure Treatment market in the U.S. is estimated at US$31.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$39.2 Billion by the year 2030 trailing a CAGR of 12.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 7.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Renal Failure Treatment Market - Key Trends & Drivers Summarized

How Is the Renal Failure Landscape Shifting Toward Integrated and Personalized Care?

Renal failure, particularly end-stage renal disease (ESRD), represents the final progression of chronic kidney disease (CKD), where the kidneys can no longer perform essential filtration and regulatory functions. Patients with ESRD require renal replacement therapy (RRT), which includes dialysis or kidney transplantation. The increasing global incidence of ESRD-driven by chronic diseases such as diabetes and hypertension-is placing immense pressure on healthcare systems to optimize both acute and long-term management strategies. This shift is prompting a re-evaluation of renal care frameworks to enhance early diagnosis, care coordination, and post-treatment support.

Integrated nephrology care models that unify screening, pharmacologic management, dietary counseling, and timely dialysis initiation are gaining momentum. Early-stage interventions such as sodium-glucose cotransporter-2 (SGLT2) inhibitors are proving effective in delaying progression to renal failure, reducing proteinuria, and lowering cardiovascular risks. These agents are now being prescribed earlier in the CKD treatment journey to reduce future dialysis dependency. Additionally, mobile health platforms and remote monitoring tools are facilitating patient engagement, particularly for home-based dialysis or pre-transplant evaluations, improving outcomes and cost-efficiency.

Which Treatment Modalities Are Evolving to Meet Complex Patient Needs?

Dialysis remains the cornerstone of renal failure management, divided into hemodialysis (HD) and peritoneal dialysis (PD). Hemodialysis, performed at centers or increasingly in homes, is supported by innovations in dialysis machines, wearable technologies, and advanced filtration membranes. On-line hemodiafiltration (HDF), which combines convective and diffusive clearance, is gaining adoption for improved toxin removal. Home hemodialysis systems are now compact, portable, and connected, enabling personalized care with fewer complications and better quality of life.

Peritoneal dialysis is also witnessing a resurgence, especially in Asia-Pacific and Latin America, due to its cost-effectiveness and patient autonomy. Automated PD machines with remote data transmission and smart fluid management are enabling safer and more efficient self-care. Kidney transplantation remains the most definitive treatment, but organ shortages, immunosuppressive complications, and eligibility limitations restrict access. To expand the transplant pool, initiatives like paired kidney exchange, desensitization protocols, and normothermic machine perfusion for donor organs are being explored. Immunotherapy and regenerative approaches such as bioartificial kidneys are in preclinical stages, offering long-term potential for ESRD management.

Which Regional Systems and Patient Populations Are Reshaping Market Priorities?

High-income countries such as the U.S., Japan, and Western Europe have mature dialysis and transplant systems, but face challenges in cost containment and aging ESRD populations. These regions are focusing on shifting dialysis to the home setting, increasing the use of telehealth, and incorporating preventive nephrology services. The U.S. Medicare ESRD program continues to evolve with bundled payments and quality-based reimbursement that reward early referral and modality diversification. Europe is investing in wearable dialysis systems and expanding donor organ utilization through policy reforms.

Emerging economies are becoming focal points for market expansion due to rising CKD incidence and government investments in nephrology infrastructure. China’s national dialysis program, India’s Pradhan Mantri National Dialysis Program, and Latin America’s PPP models are all expanding treatment access. However, affordability remains a barrier, spurring demand for low-cost dialysis machines, reusable consumables, and generic immunosuppressants. Younger ESRD patients, often affected by congenital or autoimmune causes, represent a distinct subpopulation requiring lifelong, high-quality renal care. Their presence is increasing pressure on systems to balance cost, innovation, and equitable access.

What Factors Are Driving the Growth of the Renal Failure Treatment Market?

The growth in the renal failure treatment market is driven by the rising prevalence of ESRD, expansion of dialysis infrastructure, increasing transplantation rates, and innovation in early-stage CKD therapies. As CKD continues to advance undiagnosed in many patients, health systems are investing in screening programs and chronic care pathways to delay or manage renal failure. Home dialysis solutions, AI-powered dialysis planning tools, and wearable dialysis devices are making therapy more accessible and patient-friendly.

Transplantation is receiving a boost from organ preservation technologies, living donor advocacy, and government subsidies for post-transplant care. The development of nephroprotective agents, digital adherence platforms, and hybrid treatment centers is improving care quality across the CKD-ESRD continuum. Global funding initiatives, PPP models, and strategic alliances between medtech and pharma firms are enabling market entry into underserved regions. Together, these forces are propelling the renal failure treatment market toward a future defined by precision, accessibility, and integrated chronic disease management.

SCOPE OF STUDY:

The report analyzes the Renal Failure Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment (Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment, Other Treatments); End-Use (Hospitals End-Use, Specialty Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • AbbVie Inc.
  • Akebia Therapeutics, Inc.
  • Amgen Inc.
  • Asahi Kasei Corporation
  • AstraZeneca PLC
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company (BD)
  • Calliditas Therapeutics AB
  • DaVita Inc.
  • Dialysis Clinic, Inc. (DCI)
  • Fresenius Medical Care AG & Co. KGaA
  • GSK plc
  • JMS Co., Ltd.
  • Medtronic plc
  • Nikkiso Co., Ltd.
  • NIPRO Corporation
  • Novartis AG
  • Otsuka Pharmaceutical Co., Ltd.
  • Toray Industries, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Renal Failure Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Chronic Kidney Disease Spurs Demand for Advanced Therapies
    • Expansion of Hemodialysis Infrastructure Strengthens Business Case for Treatment Accessibility
    • Growth in Transplant Waitlists Throws the Spotlight on Alternative Renal Replacement Options
    • Adoption of Home Dialysis Technologies Expands Patient-Centered Care Models
    • Pharmaceutical Advancements in Erythropoiesis-Stimulating Agents Propel Treatment Innovation
    • Rising Prevalence of Diabetes and Hypertension Accelerates Market Penetration
    • Government Investments in Kidney Health Programs Generate Access to Early-Stage Interventions
    • Advancements in Peritoneal Dialysis Fluids Drive Adoption in Ambulatory Settings
    • Increased Availability of Wearable and Portable Dialysis Systems Enhances Treatment Flexibility
    • Telemedicine Integration Improves Monitoring and Chronic Renal Care Management
    • Expansion of Kidney Disease Screening Initiatives Supports Preventive Intervention Models
    • Strategic Collaborations Between Device Makers and Providers Foster Product Accessibility
    • Inclusion of Renal Disease in UHC Plans Strengthens Reimbursement Landscape
    • Development of Artificial Kidneys Generates Long-Term Disruption Opportunities
    • Digital Platforms for Patient Engagement Improve Therapy Compliance and Outcomes
    • Demand for Individualized Treatment Plans Drives Clinical Decision Support Tools
    • Public Awareness Campaigns Highlight Importance of Early Detection and Ongoing Care
    • Improved Cold Chain Logistics Accelerate Global Distribution of Renal Therapies
    • Clinical Trial Advancements in Combination Therapies Support Pipeline Expansion
    • Rise in Geriatric Population Sustains Need for Long-Term Renal Care Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Renal Failure Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Renal Failure Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Renal Failure Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Renal Failure Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Dialysis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Dialysis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Dialysis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Kidney Transplantation Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Kidney Transplantation Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Kidney Transplantation Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Drug Therapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Drug Therapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Drug Therapy Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Treatments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Renal Failure Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Renal Failure Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Renal Failure Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Renal Failure Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Renal Failure Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Renal Failure Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Renal Failure Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Renal Failure Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Renal Failure Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Renal Failure Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Renal Failure Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Renal Failure Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION